Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: Evidence, limitaions, and implications

Current Psychiatry Reports

Volumn 5, Issue 6, 2003, Pages 469-476

  Green, Elaine ^b   Craddock, Nick ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOLIPASE C; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN;

BIPOLAR DISORDER; CHROMOSOME 11Q; FAMILY; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LINKAGE ANALYSIS; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; PATHOGENESIS; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; ANIMAL; CHROMOSOME 11; CHROMOSOME MAP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MOUSE; MOUSE MUTANT;

ANIMALS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, KNOCKOUT; POLYMORPHISM, GENETIC; RISK FACTORS; VARIATION (GENETICS);

EID: 2942633780     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-003-0086-1     Document Type: Review

References (49)

1. Sklar P, Gabriel SB, McInnis MG, et al.: Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 2002, 7:579-593.
2. Neves-Pereira M, Mundo E, Muglia P, et al.: The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002, 71:651-655.
3. Craddock N, Jones I: Genetics of bipolar disorder. J Med Genet 1999, 36:585-594.
4. Craddock N, Khodel V, Van Eerdewegh P, Reich T: Mathematical limits of multilocus models: the genetic transmission of bipolar disorder. Am J Med Genet 1995, 57:690-702.
5. Craddock N, Dave S, Greening J: Association studies of bipolar disorder. Bipolar Disord. 2001, 3:284-298.
6. Harrison PJ, Owen MJ: Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003, 361:417-419.
7. Baron M: Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 2002, 7:342-358.
8. Badner JA, Gershon ES: Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:405-411.
9. Segurado R, Detera-Wadleigh SD, Levinson DF, et al.: Genome scan meta-analysis of schizophrenia and bipolar disorder, III: bipolar disorder. Am J Hum Genet 2003, 73:49-62.
10. Preisig M, Bellivier F, Fenton BT, et al.: Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry 2000, 157:948-955.
11. Jones I, Craddock N: Candidate gene studies of bipolar disorder. Ann Med 2001, 33:248-256.
12. Anguelova M, Benkelfat C, Turecki G: A systematic review for association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 2003, 8:574-591.
13. Chumakov I, Blumenfeld M, Guerassimenko O, et al.: Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002, 99:13675-13680.
14. Hattori E, Liu C, Badner JA, et al.: Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003, 72:1131-1140.
15. Thoenen H: Neurotrophins and neuronal plasticity. Science 1995, 270:593-598.
16. Maisonpierre PC, Le Beau MM, Espinosa R, et al.: Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 1991, 10:558-568.
17. Duman RS: The neurochemistry of mood disorders: preclinical studies. In The Neurobiology of Mental Illness. Edited by Charney DS, Nestler EJ, Bunney BS. New York: Oxford University Press; 1999:333-347.
18. Hanson IM, Seawright A, van Heyningen V: The human BDNF gene maps between FSHB and HVBS1 at the boundary of 11p13-p14. Genomics 1992, 13:1331-1333.
19. Seidah NG, Benjannet S, Pareek S, et al.: Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett 1996, 379:247-50.
20. Bibel M, Barde YA: Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000, 14:2919-2937.
21. Dechant G: Molecular interactions between neurotrophin receptors. Cell Tissue Res 2001, 305:229-238.
22. Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neutrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995, 15:1768-1777.
23. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995, 15:7539-7547.
24. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP: Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001, 120:87-95.
25. Russo-Neustadt AA, Beard RC, et al.: Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000, 101:305-312.
26. Nibuya M, Nestler EJ, Duman RS: Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996, 16:2365-2372.
27. Shieh PB, Hu SC, Bobb K, et al.: Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998, 20:727-740.
28. Tao X, Finkbeiner S, Arnold DB, et al.: Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20:709-726.
29. Chen B, Dowlatshahi D, MacQueen GM, et al.: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001, 50:260-265.
30. Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998, 352:1754-1755.
31. Conti AC, Cryan JF, Dalvi A, et al.: cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 2002, 22:3262-3268.
32. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM: Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997, 56:131-137.
33. Shirayama Y, Chen AC, Nakagawa S, et al.: Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22:3251-3261.
34. Lyons WE, Mamounas LA, Ricaurte GA, et al.: Brain-derived neuroptrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 1999, 96:15239-15244.
35. Zuccato C, Ciammola A, Rigamonti D, et al.: Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001, 293:493-498.
36. Hyman SE, Nestler EJ: Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry 1996, 153:151-162.
37. Popoli M, Gennarelli M, Racagni G: Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord 2002, 4:166-182.
38. Duman RS, Malberg J, Thome J: Neuronal plasticity to stress and antidepressant treatment. Biol Psychiatry 1999, 46:1181-1191.
39. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry 1997, 54:507-606.
40. D'Sa C, Duman RS: Antidepressants and neuroplasticity. Bipolar Disord 2002, 4:183-194.
41. Craddock N, Lendon C, Cichon S, et al.: Chromosome workshop: chromosomes 11, 14, and 15. Am J Med Genet 1999, 88:244-254.
42. Zandi PP, Willour VL, Huo Y, et al.: Genome scan of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X. Am J Med Genet 2003, 119B:69-76.
43. Dick DM, Foroud T, Flury L, et al.: Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet 2003, 73:107-114.
44. Nakata K, Ujike H, Sakai A, et al.: Association study of brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003, 337:17-20.
45. Hall D, Dhilla A, Charalambous A, et al.: Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 2003, 73:370-376.
46. Ribases M, Gratacos M, Armengol L, et al.: Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry 2003, 8:745-751.
47. Muglia P, Vicente AM, Verga M, et al.: Association between the BDNF gene and schizophrenia. Mol Psychiatry 2003, 8:146-147.
48. Egan MF, Kojima M, Callicott JH, et al.: The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
49. Schulze TG, Hardy J, McMahon FJ: Inconsistent designs of association studies: a missed opportunity. Mol Psychiatry 2003, 770-772.